We, therefore, conclude that VEGF-A has a real and significant impact on the development of this hematological cancer, while FGF-2 appears to have no effect on the mechanisms of progression and development in ALL. This evidence concerns the gene FGF2 and hematopoietic and lymphoid cell neoplasm.